Tevapharm - Product Catalogue

View a listing of all Teva products.

Filters

Reset all filters

Expand All / Collapse All

Alphabet

Toggle

Product TA

Toggle

Absolute Bioavailability

Adenovirus

Advanced Solid Tumors

ALS

Amyotrophic Lateral Sclerosis

Asthma

Asthma | Chronic Obstructive Pulmonary Disease

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Emphysema | Chronic Bronchitis

Asthma | Elevated Blood Eosinophils | Oral Corticosteroid Dependence

Bioavailability and Pharmacokinetics

BiPolar

Celiac Disease

Cerebral Palsy, Dyskinetic

Chemotherapy-induced Neutropenia

Chorea

Chronic Cluster Headache

Chronic Migraine

Chronic Myeloid Leukemia

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | COPD

Chronic Pain

Cluster Headache

Cocaine Addiction

Cognitive Impairment

Contraception

Contraception | Female Contraception

COPD

Crohn's Disease

Crohn's Disease, Colitis, Ulcerative

Crohns Disease

Dementia | Alzheimer's Disease

DLBCL

Dyskinesias | Parkinson Disease | Movement Disorders

Eosinophilic Asthma

Eosinophils, Asthma

Epilepsy

Episodic Cluster Headache

Episodic Migraine Headache

Exercise-Induced Bronchoconstriction (EIB)

Exercise-induced Bronchospasm

Female, Maleergic Rhinitis

Fibromyalgia

Follicle Development | Ovarian Follicle | Follicle Count | Follicle Size | Oral Contraceptive

Glioblastoma Multiforme

Glioblastoma Multiforme|Anaplastic: Astrocytoma,Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma

Growth Hormone Deficiency

Growth Hormone-Deficiency

Healthy

Healthy Participants

Hematologic Malignancies | Solid Tumors

Hemostasis | Oral Contraceptive

Huntington Disease

Huntington's Disease

Interstitial Cystitis

Leukemia

Low Back Pain

Lupus Arthritis

Lupus Nephritis

Migraine

Migraine | Major Depressive Disorder

Migraine Headache

Migraine Prophylaxis

Multiple Sclerosis

Multiple System Atrophy

Narcolepsy

Narcolepsy | Obstructive Sleep Apnea | Shift Work Sleep Disorder

Neoplasms, Unknown Primary

Neutropenia

Non-Hodgkin Lymphoma

Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma

Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus

Optic Neuritis

Osteoarthritis of the Knee

Pain

Parkinson's Disease

Parkinson's Disease | Malignant Melanoma

Patient Satisfaction

Perennial Female, Maleergic Rhinitis

Perennial Female, Maleergic Rhinitis (PAR)

Persistent Asthma

Pharmacokinetics

Pharmacokinetics | Pharmacodynamics

Post-Traumatic Headache

Postherpetic Neuralgia

Pregnancy | Contraception

Pregnancy Prevention

Pregnancy Rate | Oocytes

Primary Progressive Multiple Sclerosis

Recurrent Glioblastoma Multiforme

Relapse Remitting Multiple Sclerosis

Relapse-Remitting Multiple Sclerosis

Relapsing Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

Respiratory

Rheumatoid Arthritis

Rhinitis, Female, Maleergic, Perennial

Schizophrenia

Schizophrenia, Schizoaffective Disorder

Seasonal Female, Maleergic Rhinitis | Hay Fever

Seasonal Female, Maleergic Rhinitis | Hayfever

Seasonal Female, Maleergic Rhinitis | SAR

Serotonin Syndrome

Solid Tumors

Stable Renal Transplant Recipients

Systemic Lupus Erythematosus

Tardive Dyskinesia

Tourette Syndrome

Vitiligo

Molecule

Toggle

Showing 1 of 1 results

All Results

No Results Found

Results per page

ProductBrandName

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Celiac Disease

A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

Product TA:: Celiac Disease

View product Primary objectives: The primary efficacy objective of the trial is to assess the ability of TEV-53408 to attenuate gluten-induced enteropathy in adults with celiac disease. The primary safety objective of the trial is to assess the safety of TEV-53408 in adults with celiac disease. Secondary objective:A secondary objective is to further assess the efficacy of TEV-53408 in adults with celiac disease.The expected trial duration per participant is approximately 86 weeks.